Navidea Biopharmaceuticals, Inc. Navidea Biopharmaceuticals, Inc.

  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Careers
  • Technology
    • Overview
    • Grant Funding
  • Pipeline
  • News & Media
    • Press Releases
    • Events
    • Publications
    • In the News
  • Investors
    • Overview
    • News / Events
    • Company Information
    • Financial Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • Contact

Press Releases

News & Media

News & Media

  • Press Releases
  • Events
  • Publications
  • In the News

Navidea Biopharmaceuticals to Announce First Quarter 2013 Financial Results Pre-market on Wednesday, May 8, 2013

May 3, 2013

Navidea Biopharmaceuticals Announces the U.S. Launch of Lymphoseek®

May 1, 2013

Navidea Biopharmaceuticals to Present at the Needham 12th Annual Healthcare Conference

Apr 25, 2013

Navidea Biopharmaceuticals Announces Underwritten Sale of Common Stock

Apr 24, 2013

Navidea Biopharmaceuticals Announces that Results of NAV4694 Clinical Trial Published in the Journal of Nuclear Medicine

Apr 18, 2013

Navidea's Presentation of Top-Line Interim Analysis of Lymphoseek® Head and Neck Phase 3 Trial Selected for Investigator Award

Apr 11, 2013

Navidea Biopharmaceuticals Retains Stern IR for Investor Relations Services

Apr 5, 2013

Navidea Biopharmaceuticals Announces Positive Top-Line Results from Interim Analysis of Lymphoseek® Phase 3 Clinical Trial in Head and Neck Cancer

Apr 4, 2013

Navidea and Collaborator Molecular Neuroimaging Enroll First Subject in NAV5001 Clinical Trial

Apr 3, 2013

Navidea Biopharmaceuticals to Present at the Future Leaders in the Biotech Industry Conference

Apr 1, 2013
    • 1...
    • 31
    • 32
    • 33
    • 34
    • 35
    • 36
    • 37
    • 38
    • 39
    • 40
    • ...43
    © 2023 Navidea Biopharmaceuticals, Inc. All Rights Reserved.
    linkedin
    Privacy Policy Disclaimer Sitemap